Trazodone in Major Affective Disorders

In summary, on the basis of our inpatient and outpatient double-blind control trials and open-label experience with trazodone, we find it to be an effective broad-spectrum antidepressant generally well tolerated by most patients. When atropine side effects of the standard tricyclic antidepressants a...

Full description

Saved in:
Bibliographic Details
Published inPsychopathology Vol. 17; no. Suppl 2; pp. 15 - 23
Main Author Feighner, John P.
Format Journal Article
LanguageEnglish
Published Basel, Switzerland 01.01.1984
Subjects
Adolescent
Adult
Aged
Clinical Trials as Topic
Depressive Disorder - drug therapy
Depressive Disorder - psychology
Double-Blind Method
Female
Humans
Imipramine - adverse effects
Imipramine - therapeutic use
Long-Term Care
Male
Middle Aged
Piperazines - therapeutic use
Psychiatric Status Rating Scales
The Role of Trazodone in Antidepression Therapy: Safety and Clinical Efficacy
Trazodone - adverse effects
Trazodone - therapeutic use
Online AccessGet full text

Cover

More Information
Summary:In summary, on the basis of our inpatient and outpatient double-blind control trials and open-label experience with trazodone, we find it to be an effective broad-spectrum antidepressant generally well tolerated by most patients. When atropine side effects of the standard tricyclic antidepressants and bridged tricyclic antidepressants are undesirable and medically contraindicated, trazodone should be one of the drugs of choice in major depressive disorders.
ISBN:3805538847
9783805538848
ISSN:0254-4962
1423-033X
DOI:10.1159/000284088